Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects
PHASE3
Randomized, open-label, multi-center, comparative trial to assess the effic...
Expanded Access Intermediate Size Treatment Protocol: Pritelivir for Immunocompromised Subjects with Treatment Resistant Herpes Simplex Virus Type 1 or 2
N/A
AiCuris Anti-infective Cures AG (AiCuris) is developing pritelivir for the ...